Ingersoll Rand
IR NYSE Industrial Machinery & Supplies & Components Financials FY2016βFY2025
Ingersoll Rand's revenue rose 5.8% to $7.7 billion in fiscal 2025. Its operating margin was 15.0%, down from 18.0% a year earlier. Free cash flow was $1.2 billion, down 2.2%. It paid out $1.0 billion in dividends and buybacks, 86% of free cash flow. The diluted share count fell 1.5%.
What Ingersoll Rand does
No business description yet.
- Legal name
- Ingersoll Rand Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-008617
0001699150
Revenue and margins
Ingersoll Rand had $7.7B of revenue in fiscal 2025, up 5.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.2B in fiscal 2025, 16.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ingersoll Rand returned $1.0B to shareholders in fiscal 2025, 86% of free cash flow. The diluted share count fell 1.5%.
Value Ingersoll Rand yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$3.5B and divides by 401.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 30.2x Β· peers 24.6x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Ingersoll Rand can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.1B | $1.6B | $1.6B | $1.5B | $1.2B |
| Debt incl. finance leases | $2.8B | $2.8B | $2.7B | $4.8B | $4.8B |
| Net debt / EBITDA | 0.7x | 0.9x | 0.7x | 1.8x | 2.1x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.5x | 0.5x |
| Interest coverage | 6.5x | 7.9x | 7.4x | 6.1x | 4.5x |
| Current ratio | 2.8x | 2.4x | 2.2x | 2.3x | 2.1x |
| Quick ratio | 2.2x | 1.8x | 1.7x | 1.7x | 1.5x |
| Total assets | $15.2B | $14.8B | $15.6B | $18.0B | $18.3B |
| Total liabilities | $6.1B | $5.5B | $5.7B | $7.8B | $8.1B |
| Shareholders' equity | $9.0B | $9.2B | $9.8B | $10.2B | $10.1B |
| Net debt (β = net cash) | $686M | $1.1B | $1.1B | $3.2B | $3.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$1.0M
1 insider
Sold, 12 months
$32.8M
7 insiders
Of sales under plans
70%
$23.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Aurobind SatpathyDirector | Bought | 11,538 | $86.68 | $1.0M | Form 4 |
| Apr 13, 2026 | Vicente ReynalSee Remarks, Director | Sold plan | 30,492 | $88.00 | $2.7M | Form 4 |
| Mar 2, 2026 | Vicente ReynalSee Remarks, Director | Sold plan | 118,044 | $94.11 | $11.1M | Form 4 |
| Feb 20, 2026 | Vikram KiniSenior Vice President and CFO | Sold | 28,367 | $96.50 | $2.7M | Form 4 |
| Feb 19, 2026 | John HumphreyDirector | Sold | 4,300 | $95.90 | $0.4M | Form 4 |
| Feb 18, 2026 | Vicente ReynalSee Remarks, Director | Sold plan | 900 | $100.00 | $0.1M | Form 4 |
| Feb 17, 2026 | Andrew R SchieslSee Remarks | Sold | 18,000 | $98.00 | $1.8M | Form 4 |
| Feb 17, 2026 | Elizabeth Meloy HepdingSee Remarks | Sold | 18,246 | $97.11 | $1.8M | Form 4 |
| Feb 17, 2026 | Kathleen M. KeeneSee Remarks | Sold | 12,000 | $99.46 | $1.2M | Form 4 |
| Feb 17, 2026 | Michael J ScheskeVP, Chief Accounting Officer | Sold | 19,122 | $97.67 | $1.9M | Form 4 |
| Feb 17, 2026 | Vicente ReynalSee Remarks, Director | Sold plan | 36,482 | $97.50 | $3.6M | Form 4 |
| Feb 13, 2026 | Vicente ReynalSee Remarks, Director | Sold plan | 55,870 | $100.39 | $5.6M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 7 / 9 | 5 / 9 |
| Accruals ratio | β4.0% | β3.3% | β4.3% |
| Altman Z'' | 3.60 | 3.18 | 3.06 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Ingersoll Rand IR | $28.8B | 5.8% | 15.0% | 16.0% | 6.5% | 30.2x | 5 | |
| Dover DOV | $26.9B | 4.5% | 17.0% | 13.8% | 12.0% | 23.2x | 5 | Compare β |
| Xylem XYL | $25.7B | 5.5% | 13.5% | 10.1% | 8.1% | 25.9x | 6 | Compare β |
| Hubbell HUBB | $23.9B | 3.8% | 20.7% | 15.0% | 18.7% | 26.5x | 7 | Compare β |
| Snap-on SNA | $18.7B | 0.9% | 25.8% | 19.5% | 19.2% | 18.6x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.9B | $2.4B | $2.7B | $2.0B | $4.0B | $5.2B | $5.9B | $6.9B | $7.2B | $7.7B |
| Gross profit | $717M | $898M | $1.0B | $778M | $1.4B | $2.0B | $2.3B | $2.9B | $3.2B | $3.3B |
| Research and development | $22.0M | $26.0M | $24.0M | $22.0M | $58.0M | $74.0M | $91.3M | $108M | $117M | $114M |
| Operating income | $104M | $109M | $443M | $194M | $59.6M | $566M | $817M | $1.2B | $1.3B | $1.1B |
| Interest expense | $170M | $141M | $99.6M | $88.4M | $111M | $87.7M | $103M | $157M | $213M | $254M |
| Pretax income | β$63.2M | β$113M | $350M | $110M | β$45.4M | $513M | $742M | $1.0B | $1.1B | $935M |
| Income tax | β$31.9M | β$131M | $80.1M | $12.9M | $11.4M | β$21.8M | $150M | $240M | $263M | $219M |
| Net income | β$36.6M | $18.4M | $269M | $159M | β$33.3M | $563M | $605M | $779M | $839M | $581M |
| Diluted EPS | β$0.25 | $0.10 | $1.29 | $0.76 | β$0.09 | $1.34 | $1.47 | $1.90 | $2.06 | $1.45 |
| Diluted shares | 0.15B | 0.19B | 0.21B | 0.21B | 0.38B | 0.42B | 0.41B | 0.41B | 0.41B | 0.40B |
| Cash flow | ||||||||||
| Cash from operations | $166M | $201M | $445M | $343M | $914M | $628M | $865M | $1.4B | $1.4B | $1.4B |
| Capital expenditure | $74.4M | $56.8M | $52.2M | $37.9M | $42.0M | $64.1M | $94.6M | $105M | $149M | $136M |
| Free cash flow | $91.2M | $144M | $392M | $305M | $872M | $564M | $771M | $1.3B | $1.2B | $1.2B |
| Depreciation and amortization | $173M | $174M | $180M | $147M | $413M | $422M | $433M | $459M | $482M | $506M |
| Stock-based compensation | $0.0M | $175M | $2.8M | $18.7M | $47.5M | $87.2M | $78.9M | $51.9M | $58.8M | $53.0M |
| Acquisitions | $18.8M | $18.8M | $186M | $12.0M | $9.0M | $975M | $247M | $963M | $3.0B | $525M |
| Share buybacks | $14.1M | $3.6M | $40.7M | $18.6M | $2.1M | $737M | $261M | $263M | $261M | $1.0B |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $8.2M | $32.4M | $32.4M | $32.3M | $31.8M |
| Dividends and buybacks | $14.1M | $3.6M | $40.7M | $18.6M | $2.1M | $745M | $294M | $295M | $293M | $1.0B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $256M | $393M | $221M | $506M | $1.8B | $2.1B | $1.6B | $1.6B | $1.5B | $1.2B |
| Total debt | $2.8B | $2.0B | $1.7B | $1.6B | $3.9B | $2.8B | $2.8B | $2.7B | $4.8B | $4.8B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $17.9M | $17.2M | $17.1M | $16.1M | $14.9M | $13.9M | $12.5M |
| Current assets | $1.2B | $1.5B | $1.3B | $1.5B | $3.9B | $4.1B | $4.0B | $4.1B | $4.2B | $4.2B |
| Current liabilities | $498M | $562M | $596M | $575M | $1.5B | $1.5B | $1.7B | $1.8B | $1.8B | $2.1B |
| Inventory | $444M | $495M | $524M | $503M | $717M | $854M | $1.0B | $1.0B | $1.1B | $1.2B |
| Property and equipment, net | $358M | $363M | $357M | $327M | $609M | $649M | $624M | $711M | $842M | $930M |
| Total assets | $4.3B | $4.6B | $4.5B | $4.6B | $16.1B | $15.2B | $14.8B | $15.6B | $18.0B | $18.3B |
| Total liabilities | $4.0B | $3.1B | $2.8B | $2.8B | $6.9B | $6.1B | $5.5B | $5.7B | $7.8B | $8.1B |
| Shareholders' equity | $266M | $1.5B | $1.7B | $1.9B | $9.1B | $9.0B | $9.2B | $9.8B | $10.2B | $10.1B |
| Margins | ||||||||||
| Gross margin | 37.0% | 37.8% | 37.6% | 38.6% | 35.4% | 38.6% | 39.3% | 41.9% | 43.8% | 43.6% |
| Operating margin | 5.3% | 4.6% | 16.5% | 9.6% | 1.5% | 11.0% | 13.8% | 16.9% | 18.0% | 15.0% |
| EBITDA margin | 14.2% | 11.9% | 23.2% | 16.9% | 11.9% | 19.2% | 21.1% | 23.6% | 24.6% | 21.6% |
| Net margin | β1.9% | 0.8% | 10.0% | 7.9% | β0.8% | 10.9% | 10.2% | 11.3% | 11.6% | 7.6% |
| FCF margin | 4.7% | 6.1% | 14.6% | 15.1% | 22.0% | 10.9% | 13.0% | 18.5% | 17.2% | 16.0% |
| Returns | ||||||||||
| Return on capital | β | 2.9% | 10.9% | 5.6% | 0.7% | 5.4% | 6.5% | 8.4% | 8.2% | 6.5% |
| Return on capital employed | β | 2.8% | 11.1% | 4.9% | 0.6% | 4.0% | 6.1% | 8.7% | 8.7% | 7.1% |
| Return on equity | β10.9% | 2.1% | 17.1% | 9.0% | β0.6% | 6.2% | 6.7% | 8.2% | 8.4% | 5.7% |
| Return on assets | β0.8% | 0.4% | 5.9% | 3.5% | β0.3% | 3.6% | 4.0% | 5.1% | 5.0% | 3.2% |
| Growth | ||||||||||
| Revenue growth | β8.8% | 22.5% | 13.2% | β25.0% | 96.9% | 29.7% | 14.8% | 16.2% | 5.2% | 5.8% |
| Net income growth | β | β | 1,364.1% | β40.9% | β120.9% | β | 7.5% | 28.8% | 7.7% | β30.7% |
| EPS growth | β | β | 1,190.0% | β41.1% | β111.8% | β | 9.7% | 29.3% | 8.4% | β29.6% |
| FCF growth | β9.8% | 57.6% | 173.0% | β22.2% | 185.6% | β35.4% | 36.7% | 65.0% | β1.9% | β2.2% |
| Share count change | β0.3% | 26.3% | 11.0% | β0.1% | 83.3% | 10.0% | β2.6% | β0.3% | β0.4% | β1.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 9.1x | 5.8x | 2.3x | 3.3x | 4.6x | 0.7x | 0.9x | 0.7x | 1.8x | 2.1x |
| Debt / equity | 10.5x | 1.4x | 1.0x | 0.9x | 0.4x | 0.3x | 0.3x | 0.3x | 0.5x | 0.5x |
| Interest coverage | 0.6x | 0.8x | 4.5x | 2.2x | 0.5x | 6.5x | 7.9x | 7.4x | 6.1x | 4.5x |
| Current ratio | 2.4x | 2.6x | 2.2x | 2.7x | 2.6x | 2.8x | 2.4x | 2.2x | 2.3x | 2.1x |
| Quick ratio | 1.5x | 1.7x | 1.4x | 1.8x | 2.1x | 2.2x | 1.8x | 1.7x | 1.7x | 1.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.8% | 2.4% | 1.9% | 1.9% | 1.1% | 1.2% | 1.6% | 1.5% | 2.1% | 1.8% |
| Stock comp / revenue | 0.0% | 7.4% | 0.1% | 0.9% | 1.2% | 1.7% | 1.3% | 0.8% | 0.8% | 0.7% |
| Payouts / FCF | 15.5% | 2.5% | 10.4% | 6.1% | 0.2% | 132.2% | 38.1% | 23.2% | 23.5% | 86.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 8.0 | 6.0 | 7.0 | 3.0 | 7.0 | 7.0 | 8.0 | 7.0 | 5.0 |
| Altman Z'' | 0.8 | 1.5 | 2.1 | 2.3 | 2.4 | 3.0 | 3.4 | 3.6 | 3.2 | 3.1 |
| Accruals ratio | β4.6% | β4.1% | β3.8% | β4.0% | β9.2% | β0.4% | β1.7% | β4.0% | β3.3% | β4.3% |
Source: SEC EDGAR XBRL filings (CIK 0001699150). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.